Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6398)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 24, 2023 (publication date) through Aug 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rao ZZ, Tang ZW, Wen J. Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor. World J Clin Oncol 2023; 14(9): 335-342 [PMID: 37771631 DOI: 10.5306/wjco.v14.i9.335] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i9/335.htm |
| Number | Citing Articles |
| 1 |
Kunhong Mao, Can Liu, Zhongwen Tang, Zhouzhou Rao, Jie Wen. Advances in drug resistance of osteosarcoma caused by pregnane X receptor. Drug Metabolism Reviews 2024; 56(4): 385 doi: 10.1080/03602532.2024.2366948
|
| 2 |
Coralie Carivenc, Guillaume Laconde, Pauline Blanc, Muriel Amblard, William Bourguet, Vanessa Delfosse. A two-in-one expression construct for biophysical and structural studies of the human pregnane X receptor ligand-binding domain, a pharmaceutical and environmental target. Acta Crystallographica Section F Structural Biology Communications 2025; 81(3): 85 doi: 10.1107/S2053230X2500069X
|
| 3 |
Dominika Radomska, Robert Czarnomysy, Krzysztof Marciniec, Justyna Nowakowska, Enrique Domínguez-Álvarez, Krzysztof Bielawski. Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells. International Journal of Molecular Sciences 2024; 25(17): 9732 doi: 10.3390/ijms25179732
|
| 4 |
Feifei Zhuang, Shaoyan Huang, Lei Liu. PYCR3 modulates mtDNA copy number to drive proliferation and doxorubicin resistance in triple-negative breast cancer. The International Journal of Biochemistry & Cell Biology 2024; 171: 106581 doi: 10.1016/j.biocel.2024.106581
|
| 5 |
Mohammed O. Gbadamosi, Neha Bhise, Taraswi Mitra Ghosh, Elizabeth K. Molchan, Kathleen Streeks, Jason Puglise, Alyssa Ohaegbulam, Mariana Makarem, Oluwaseyi Olabige, Changlin Yang, Luisel Ricks-Santi, Duane A. Mitchell, Brooke L. Fridley, Jatinder K. Lamba. A genome-wide association study using HapMap cell lines reveals modulators of cellular response to cyclophosphamide. Future Oncology 2025; 21(14): 1809 doi: 10.1080/14796694.2025.2501517
|
| 6 |
Evangelos Koustas, Panagiotis Sarantis, Eleni-Myrto Trifylli, Eleftheria Dikoglou-Tzanetatou, Evangelia Ioakeimidou, Ioanna A. Anastasiou, Michalis V. Karamouzis, Stamatios Theocharis. Autophagy and PXR Crosstalk in the Regulation of Cancer Drug Metabolism and Resistance According to Gene Mutational Status in Colorectal Cancer. Genes 2025; 16(8): 892 doi: 10.3390/genes16080892
|
| 7 |
Shazia Sabir, Ali Salman Bin Thani, Qamar Abbas. Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance. Frontiers in Bioengineering and Biotechnology 2025; 13 doi: 10.3389/fbioe.2025.1548588
|